News

Single dose of the pneumococcal conjugate vaccine is used for active immunization against pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumonia in individuals falling under expanded

Under the revised agreement, Merck gains expanded access to Adimab’s technology for the discovery and optimization of fully human antibody candidates. Adimab will develop therapeutic antibody candidates against

The study is designed to assess the possible immune biomarkers in both tumor tissue and peripheral blood subsequent to intralesional PV-10 injection of melanoma tumors. The University of

The study conducted in a single center was designed to assess the safety, side effect profile in addition to pharmacokinetic and pharmacodynamic profile of varying doses of Somatoprim.

The collaboration will utilize Priaxon’s small molecule drug discovery knowledge in chemistry and technology that is especially suitable for investigating the modulation of PPIs and GSK’s resources and

The hyperimmune product that contains antibodies specific for the Varicella zoster virus is intended to reduce the severity of chickenpox infections in the patients. Cangene president and chief

Inducing programmed necrosis, the quinone-based compounds activate the molecular pathway that causes the premature death of cancerous cells and tissue. The compounds are also able to target various

Lilly also considers initiating remaining pre-planned trials to assess the safety, efficacy and differentiation of LY2605541 in 2013 and 2014 while five IMAGINE clinical trials are being conducted

The primary efficacy endpoint of the studies was defined as a significant change in HbA1c from baseline compared to placebo with empagliflozin 10mg and 25mg once daily doses.